Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Translation in Brief

Melanoma vs. melanoma

PEDF-presenting exosomes may be able to prevent metastasis of melanoma

January 25, 2018 8:31 PM UTC

A Northwestern University team has discovered that some non-metastatic melanoma cells carry a signal, pigment epithelium derived factor (PEDF), that can induce immune-mediated killing of metastatic cells, pointing toward a new immunotherapeutic strategy for the disease.

Exosomes mediate communication between cells and have previously been shown to help tumors create an immunosuppressive environment. But in their study published in Nature Communications, the Northwestern researchers found the opposite can also be true: exosomes from pre-metastatic melanomas can stimulate a cancer-killing immune response...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article